CrushSCI.com
181.1平均天数
113.5中位天数
19最短天数
973最长天数
282025发文量

Paper Review Records

全部论文审稿周期

16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

973 天

Decisional conflict among patients with prostate cancer considering germline testing

作者
Liam Gima-Lange; Kelly Gordon; Barry Tong; Amie Blanco; Daniel H. Kwon展开收起
作者单位
1. Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, USA; 2. Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, USA; 3. Department of Medicine, University of California San Francisco, San Francisco, USA展开收起
PDF源文件 DOI 网页
220 天

BRCA2 reversion mutations as a resistance mechanism to olaparib in patients with BRCA2 -mutated mCRPC: a case series

作者
Kohji Takemura; Ayumi Abe; Kazushige Sakaguchi; Shinji Urakami; Masami Arai; Yuji Miura展开收起
作者单位
1. Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan; 2. Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; 3. Clinical Genetics Center, Toranomon Hospital, Tokyo, Japan; 4. Department of Clinical Genetics, Graduate School of Medicine, Juntendo University, Tokyo, Japan; 5. Department of Urology, Toranomon Hospital, Tokyo, Japan; 6. Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan展开收起
PDF源文件 DOI 网页
77 天

Awareness of hereditary breast cancer and readiness for genetic testing among newly diagnosed patients with breast cancer in Nigeria: a multicentre study

作者
Funmilola O. Wuraola; Jenine Ramruthan; Victoria L. Mango; Nneka Sunday-Nweke; Olayide Agodirin; Anna Dare; Adewale A. Aderounmu; Mary Ogunyemi; Boladuro Olawale; Saheed Lawal; Anna T. Santiago; Olalekan Olasehinde; Adewale O. Adisa; Emma Reel; Olusegun I. Alatise; Tulin D. Cil展开收起
作者单位
1. Department of Surgery, Faculty of Clinical Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria; 2. African Research Group for Oncology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria; 3. Department of General Surgery, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada; 4. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA; 5. Department of Surgery, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Nigeria; 6. Department of Surgery, University of Ilorin, Ilorin, Nigeria; 7. Department of Surgery, University of Toronto, Toronto, Canada; 8. Department of Surgery, Dalla Lana School of Public Health, Toronto, Canada; 9. Department of Biostatistics, University Health Network, Toronto, Canada展开收起
PDF源文件 DOI 网页
51 天

Trends in the uptake of nipple sparing mastectomy in BRCA1/2 , PALB2 and other pathogenic variant carriers undergoing risk reducing mastectomy

作者
Marya Alsuhaibani; Amel Melanson; Alex Viezel-Mathieu; Tassos Dionisopoulos; Mark Basik; Jean Francois Boileau; Karyne Martel; Sarkis Meterissian; Joshua Vorstenbosch; Victor Villareal-Corpuz; William D. Foulkes; Ipshita Prakash; Stephanie M. Wong展开收起
作者单位
1. Department of Surgery, McGill University, Montreal, Canada; 2. Stroll Cancer Prevention Centre, Jewish General Hospital, Montreal, Canada; 3. Department of Plastic and Reconstructive Surgery, McGill University, Montreal, Canada; 4. Department of Oncology, McGill University, Montreal, Canada; 5. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; 6. Department of Human Genetics, McGill University, Montreal, Canada; 7. Segal Cancer Centre, Jewish General Hospital, Montreal, Canada展开收起
PDF源文件 DOI 网页
119 天

Barriers and facilitators of adherence to cancer prevention in Lynch Syndrome: an integrative review

作者
Marjorie Matekwa; Margaret H. White; Janet H. Van Cleave; Veronica J. Brady; Carina Katigbak展开收起
作者单位
1. Cizik School of Nursing, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, USA展开收起
PDF源文件 DOI 网页
103 天

The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer

作者
Matthew Hogben; Emma Hainsworth; Barbara Benton; Jana McHugh; Kathryn Myhill; Eva McGrowder; Reshma Rageevakumar; Denzil James; Sarah Benafif; Elizabeth C. Page; Rosalind A. Eeles; Emma Rowland; Elizabeth K. Bancroft展开收起
作者单位
1. Oncogenetics Research Team, The Royal Marsden NHS Foundation Trust, London, UK; 2. Oncogenetics Research Team, The Institute of Cancer Research, London, UK; 3. University College London Hospitals NHS Foundation Trust, London, UK; 4. Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King’s College London, London, UK展开收起
PDF源文件 DOI 网页

FAQ

Hereditary Cancer in Clinical Practice审稿要多久?

截至2026-11-19,CrushSCI 收录了 Hereditary Cancer in Clinical Practice 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 19 天(Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men,2026-05-13 收稿,2026-06-01 录用),最慢一篇用了 973 天;平均 181.1 天,中位数 113.5 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。